← Open Payments lookup

ALISHA FANGMEYER: Open Payments

NPI 1568756609 · SUPERIOR, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$291 in 17 payments from 8 companies in 2025. Trend: 2023 $538 · 2024 $378 · 2025 $291

Food & beverage: $291
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$70
Gilead Sciences, Inc.4$68
Novo Nordisk Inc3$47
ABBVIE INC.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Axsome Therapeutics, Inc.1$17
Amgen Inc.1$16
Janssen Pharmaceuticals, Inc1$14

Products named: REXULTI, Ozempic, VRAYLAR, CAPLYTA, Auvelity, EVENITY, Epclusa, SPRAVATO.

Industry payments across NE — which companies pay providers there.